Monocyte/HDL-cholesterol ratio predicts the definite stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

Biomark Med. 2015;9(10):967-77. doi: 10.2217/bmm.15.74. Epub 2015 Oct 6.

Abstract

Aim: We investigated the predictive value of monocyte count to HDL ratio (M/H ratio) for stent thrombosis (ST) in ST elevation myocardial infarction (STEMI).

Patients & methods: 1170 STEMI patients treated with primary PCI were followed-up for a median of 37.2 months.

Results: During follow-up, 112 patients were diagnosed as 'definite' ST. The rate of ST was significantly highest in the third M/H ratio tertile. In Cox regression analysis, adjusted for other factors, having an M/H ratio in third tertile had a 2.2-fold increased risk of ST. Kaplan-Meier analysis revealed the higher occurrence of ST in the third tertile compared with others (p <0.001).

Conclusion: M/H ratio as a novel marker of inflammation seemed to be an independent predictor of ST in STEMI patients.

Keywords: PCI; ST elevation myocardial infarction; inflammation; monocyte to HDL ratio; stent thrombosis.

MeSH terms

  • Cholesterol, HDL / blood*
  • Electrocardiography*
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Leukocyte Count
  • Male
  • Middle Aged
  • Monocytes / cytology*
  • Myocardial Infarction / physiopathology*
  • Myocardial Infarction / therapy
  • Percutaneous Coronary Intervention / adverse effects*
  • Prognosis
  • Stents / adverse effects*
  • Thrombosis / blood*
  • Thrombosis / diagnosis
  • Thrombosis / etiology

Substances

  • Cholesterol, HDL